Chen, Yuntao https://orcid.org/0000-0002-2536-3524
Voors, Adriaan A.
Jaarsma, Tiny
Lang, Chim C.
Sama, Iziah E.
Akkerhuis, K. Martijn
Boersma, Eric
Hillege, Hans L.
Postmus, Douwe
Article History
Received: 11 September 2020
Accepted: 21 December 2020
First Online: 27 January 2021
Ethics approval and consent to participate
: This study was approved by all relevant local ethics committees. All patients provided written informed consent.
: Not applicable.
: Dr. Voors reports personal fees from Amgen, personal fees from Cytokinetics, personal fees from Boehringer Ingelheim, grants and personal fees from Roche, personal fees from Novartis, personal fees from AstraZeneca, personal fees from Bayer, personal fees from Myokardia, and personal fees from Merck, outside the submitted work. All the other authors declared no conflicts of interest.